Zymenex develops pharmaceutical products to treat rare, serious and genetic diseases. The company’s goal is to develop a successive number of enzyme replacement therapies for diseases, which may have an orphan drug potential.
If you can't find it here or have feedback to our website, please do not hesitate to contact email@example.com or +45 5150 0560
Copyright 2010 Danskbiotek. All rights reserved.
created by: Mastafu Design